Journal of Neuro-Oncology

Article	Citations
Convection-enhanced drug delivery for glioblastoma: a review	67
Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trial	58
Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database	53
Intraoperative MRI for Brain Tumors	51
Laser interstitial thermotherapy (LITT) for the treatment of tumors of the brain and spine: a brief review	49
High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entity	48
Combination immunotherapy strategies for glioblastoma	43
Neurotoxicities associated with immune checkpoint inhibitor therapy	43
Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review	40
Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review	39
Focused ultrasound for the treatment of glioblastoma	38
Label-free brain tumor imaging using Raman-based methods	34
Surgical strategy for insular glioma	33
Sonodynamic therapy for gliomas	31
Molecular diagnosis of diffuse glioma using a chip-based digital PCR system to analyze IDH, TERT, and H3 mutations in the cerebrospinal fluid	31
MRI radiomics to differentiate between low grade glioma and glioblastoma peritumoral region	28
The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study	28
Local control and patterns of failure for “Radioresistant” spinal metastases following stereotactic body radiotherapy compared to a “Radiosensitive” reference	28
Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis	27
LAG-3 expression in the inflammatory microenvironment of glioma	27
Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis	27
Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis	26
A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma	25
Radiomics for precision medicine in glioblastoma	25
Cyproterone acetate and meningioma: a nationwide-wide population based study	25

Intracranial solitary fibrous tumor/hemangiopericytoma: tumor reclassification and assessment of treatment outcome via the 2016 WHO classification	24
Association of baseline frailty status and age with postoperative morbidity and mortality following intracranial meningioma resection	24
Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation	24
Characteristics of IDH-mutant gliomas with non-canonical IDH mutation	23
PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma	23
Update on management of craniopharyngiomas	23
Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation	22
Implementation, relevance, and virtual adaptation of neuro-oncological tumor boards during the COVID-19 pandemic: a nationwide provider survey	22
Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases	22
Modern endoscopic skull base neurosurgery	22
The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes	21
H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients	21
Biomarkers and focused ultrasound: the future of liquid biopsy for brain tumor patients	21
A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma	21
The role of imaging for the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update	20
Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma	20
Profiling of the immune landscape in murine glioblastoma following blood brain/tumor barrier disruption with MR image-guided focused ultrasound	20
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma	20
Quantitative mapping of individual voxels in the peritumoral region of IDH-wildtype glioblastoma to distinguish between tumor infiltration and edema	20
Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas	20
Quantitative assessment of circulating tumor cells in cerebrospinal fluid as a clinical tool to predict survival in leptomeningeal metastases	19
Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma	19
Immune checkpoint inhibitors in GBM	19
Resected WHO grade I meningioma and predictors of local control	19
Unexpected hubness: a proof-of-concept study of the human connectome using pagerank centrality and implications for intracerebral neurosurgery	19
Impact of the extent of resection on the survival of patients with grade II and III gliomas using awake brain mapping	19
Functional connectivity of the default mode, dorsal attention and fronto-parietal executive control networks in glial tumor patients	19
The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update	18
Radiotherapy for meningiomas	18
Updates on the WHO diagnosis of IDH-mutant glioma	18
Awake surgery for right frontal lobe glioma can preserve visuospatial cognition and spatial working memory	18
T7 peptide-decorated exosome-based nanocarrier system for delivery of Galectin-9 siRNA to stimulate macrophage repolarization in glioblastoma	18
Current state of therapeutic focused ultrasound applications in neuro-oncology	18
Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review	18
Emerging systemic treatment options in meningioma	18
Extent of resection and survival outcomes in World Health Organization grade II meningiomas	18
Radiation necrosis or tumor progression? A review of the radiographic modalities used in the diagnosis of cerebral radiation necrosis	17
Trastuzumab emtansine increases the risk of stereotactic radiosurgery-induced radionecrosis in HER2 + breast cancer	17
Physical activity and exercise in adults diagnosed with primary brain cancer: a systematic review	17
Cytoreductive surgery in the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update	17
Salvage resection of recurrent previously irradiated brain metastases: tumor control and radiation necrosis dependency on adjuvant re-irradiation	16
The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age	16
Thalamic gliomas in adults: a systematic review of clinical characteristics, treatment strategies, and survival outcomes	16
Final results of the Choroid Plexus Tumor study CPT-SIOP-2000	16
Neuropsychological outcomes following supratotal resection for high‐grade glioma: a review	16
Carer preparedness improved by providing a supportive educational intervention for carers of patients with high-grade glioma: RCT results	16
Adult diffuse midline gliomas H3 K27-altered: review of a redefined entity	16
Predictors of long-term tumor control after stereotactic radiosurgery for Koos grade 4 vestibular schwannomas	16
The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring	16
eHealth cognitive rehabilitation for brain tumor patients: results of a randomized controlled trial	16

Medulloblastoma recurrence and metastatic spread are independent of colony-stimulating factor 1 receptor signaling and macrophage survival	16
Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection	16
How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians	16
Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?	15
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of radiation therapy in the management of progressive and recurrent glioblastoma in adults	15
Long-term outcomes of grade I/II skull base chondrosarcoma: an insight into the role of surgery and upfront radiotherapy	15
Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US	15
The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications	15
Predicting response to radiotherapy of intracranial metastases with hyperpolarized $$^{13}$$C MRI	15
Predictors of postoperative biochemical remission in acromegaly	15
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysis	15
PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression	15
Stereotactic radiosurgery for vestibular schwannomas in neurofibromatosis type 2 patients: a systematic review and meta-analysis	15
Sonodynamic therapy and magnetic resonance-guided focused ultrasound: new therapeutic strategy in glioblastoma	15
Predicting access to postoperative treatment after glioblastoma resection: an analysis of neighborhood-level disadvantage using the Area Deprivation Index (ADI)	14
Inter-fraction dynamics during post-operative 5 fraction cavity hypofractionated stereotactic radiotherapy with a MR LINAC: a prospective serial imaging study	14
Clinical significance of checkpoint regulator “Programmed death ligand-1 (PD-L1)” expression in meningioma: review of the current status	14
A volume matched comparison of survival after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases	14
Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases	14
Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade	14
Presentation, imaging, patterns of care, growth, and outcome in sporadic and von Hippel–Lindau-associated central nervous system hemangioblastomas	14
A deep learning model for discriminating true progression from pseudoprogression in glioblastoma patients	14
The Clinical Frailty Scale as useful tool in patients with brain metastases	14
Cervical chordomas: multicenter case series and meta-analysis	14
Fluid attenuation in non‐contrast‐enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma	14
The Clinical Frailty Scale as predictor of overall survival after resection of high-grade glioma	13
Single- and hypofractionated stereotactic radiosurgery for large (> 2 cm) brain metastases: a systematic review	13
Diffusion tractography for awake craniotomy: accuracy and factors affecting specificity	13
Static FET PET radiomics for the differentiation of treatment-related changes from glioma progression	13
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas	13
IDH1 p.R132H ctDNA and D-2-hydroxyglutarate as CSF biomarkers in patients with IDH-mutant gliomas	13
ERK inhibition in glioblastoma is associated with autophagy activation and tumorigenesis suppression	13
Effect of antiepileptic drugs in glioma patients on self-reported depression, anxiety, and cognitive complaints	13
Utility of hospital frailty risk score for predicting postoperative outcomes in craniopharyngioma	13
Meningiomas and cyproterone acetate: a retrospective, monocentric cohort of 388 patients treated by surgery or radiotherapy for intracranial meningioma	13
Radiation-induced brain injury in patients with meningioma treated with proton or photon therapy	13
Leptomeningeal metastases: the future is now	13
Circ_CLIP2 promotes glioma progression through targeting the miR-195-5p/HMGB3 axis	13
Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas	13
Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant	13
Long term outcomes following surgery for pineal region tumors	12
Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography	12
What effects does awake craniotomy have on functional and survival outcomes for glioblastoma patients?	12
Low MGMT digital expression is associated with a better outcome of IDH1 wildtype glioblastomas treated with temozolomide	12
The application of fluorescein sodium for the resection of medulloblastoma	12
Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis	12
Optimizing stereotactic radiosurgery in patients with recurrent or residual craniopharyngiomas	12
Interstitial photodynamic therapy for newly diagnosed glioblastoma	12
Effect of adjuvant radiotherapy after subtotal resection for WHO grade I meningioma: a propensity score matching analysis of the Brain Tumor Registry of Japan	12
The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide	12
Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study	12
Gyriform infiltration as imaging biomarker for molecular glioblastomas	12
Evolution of the neurosurgical management of progestin‐associated meningiomas: a 23-year single‐center experience	12
Clinical characteristics and long-term surgical outcome of spinal myxopapillary ependymoma: a French cohort of 101 patients	12
DNA damage in IDH-mutant gliomas: mechanisms and clinical implications	12
Guidelines in the management of CNS tumors	12
The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients	12
Frameless robot-assisted stereotactic biopsies for lesions of the brainstem—a series of 103 consecutive biopsies	12
Atypical teratoid/rhabdoid tumor in adults: a systematic review of the literature with meta-analysis and additional reports of 4 cases	12
Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease	12
Immune-related aseptic meningitis and strategies to manage immune checkpoint inhibitor therapy: a systematic review	12
Short and long-term prognostic value of intraoperative motor evoked potentials in brain tumor patients: a case series of 121 brain tumor patients	12
Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines	12
Mortality trends in primary malignant brain and central nervous system tumors vary by histopathology, age, race, and sex	12
Surgery on giant meningiomas in very old patients entails frequent postoperative intracranial hemorrhages and atypical histopathology	11
Tumor location-based classification of surgery-related language impairments in patients with glioma	11
Time from stereotactic radiosurgery to immunotherapy in patients with melanoma brain metastases and impact on outcome	11
Pattern of technology diffusion in the adoption of stereotactic laser interstitial thermal therapy (LITT) in neuro-oncology	11
Management of multiple brain metastases: a patterns of care survey within the German Society for Radiation Oncology	11
Surgical strategies for older patients with glioblastoma	11
The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery	11
The effect of levetiracetam treatment on survival in patients with glioblastoma: a systematic review and meta-analysis	11
Molecular classification and grading of meningioma	11
Eigenvector PageRank difference as a measure to reveal topological characteristics of the brain connectome for neurosurgery	11
Leptomeningeal disease in glioblastoma: endgame or opportunity?	11
Local and distant brain control in melanoma and NSCLC brain metastases with concurrent radiosurgery and immune checkpoint inhibition	11
Second surgery for progressive glioblastoma: a multi‐centre questionnaire and cohort‐based review of clinical decision‐making and patient outcomes in current practice	11
Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma	11
Bone metastasis from glioblastoma: a systematic review	11
Hormone therapies in meningioma-where are we?	11

Impact of the COVID-19 pandemic on neuro-oncology outcomes	11
A contemporary update on glioblastoma: molecular biology, current management, and a vision towards bio-adaptable personalized care	11
Survival after resection of brain metastasis: impact of synchronous versus metachronous metastatic disease	11
Risks and neurological benefits of meningioma surgery in elderly patients compared to young patients	11
Initial results of a phase II trial of 18F-DOPA PET-guided re-irradiation for recurrent high-grade glioma	11
Radiotherapy alone for pediatric patients with craniopharyngioma	11
Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825	11
Outcomes of salvage radiation for recurrent world health organization grade II meningiomas: a retrospective cohort study	10
Cranial sonolucent prosthesis: a window of opportunity for neuro-oncology (and neuro-surgery)	10
Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): a systematic review	10
Decision making and surgical modality selection in glioblastoma patients: an international multicenter survey	10
Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis	10
Clinical outcomes as a function of the number of samples taken during stereotactic needle biopsies: a meta-analysis	10
Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial	10
Cerebrospinal fluid diversion for leptomeningeal metastasis: palliative, procedural and oncologic outcomes	10
Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients	10
miR-497 and 219 in blood aid meningioma classification	10
MMSE is an independent prognostic factor for survival in primary central nervous system lymphoma	10
Fluorescence guided surgery for pituitary adenomas	10
Incidence and characteristics of metastatic intracranial lesions in stage III and IV melanoma: a single institute retrospective analysis	10
Transcranial magnetic stimulation for post-operative neurorehabilitation in neuro-oncology: a review of the literature and future directions	10
18F-FET-PET-guided gross total resection improves overall survival in patients with WHO grade III/IV glioma: moving towards a multimodal imaging-guided resection	10
Pre-operative MRI radiomics model non-invasively predicts key genomic markers and survival in glioblastoma patients	10
5-ALA kinetics in meningiomas: analysis of tumor fluorescence and PpIX metabolism in vitro and comparative analyses with high-grade gliomas	10
Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas	10
Long-term disease control and treatment outcomes of stereotactic radiosurgery in cavernous sinus meningiomas	10
Correlation of reduced temporal muscle thickness and systemic muscle loss in newly diagnosed glioblastoma patients	10
The epidemiology of primary and metastatic brain tumors in infancy through childhood	10
Sex as a prognostic factor in adult-type diffuse gliomas: an integrated clinical and molecular analysis according to the 2021 WHO classification	10
The role of single-fraction stereotactic radiosurgery for atypical meningiomas (WHO grade II): treatment results based on a 25-year experience	10
Glioblastoma cells potentiate the induction of the Th1-like profile in phosphoantigen-stimulated γδ T lymphocytes	10
Salvage resection plus cesium-131 brachytherapy durably controls post-SRS recurrent brain metastases	10
Stereotactic radiosurgery in the management of petroclival meningiomas: a systematic review and meta-analysis of treatment outcomes of primary and adjuvant radiosurgery	9
Stereotactic radiosurgery for Koos grade IV vestibular schwannoma in young patients: a multi-institutional study	9
Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort	9
Technical choices significantly alter the adaptive immune response against immunocompetent murine gliomas in a model-dependent manner	9
Surgical strategies for intracranial meningioma in the molecular era	9
The evolution of stereotactic radiosurgery in neurosurgical practice	9
Cellular senescence in glioma	9
Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial	9
Clinical and radiographic characteristics of diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma: a single institution review	9
Incidence trends and survival analysis of atypical meningiomas: a population-based study from 2004 to 2018	9
Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma	9
Gamma knife icon based hypofractionated stereotactic radiosurgery (GKI-HSRS) for brain metastases: impact of dose and volume	9
Long-term outcomes of spinal ependymomas: an institutional experience of more than 60 cases	9
Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS)	9
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma	9
Molecular matched targeted therapies for primary brain tumors—a single center retrospective analysis	9
Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblasto	9
Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review	9
Early EEG hyperexcitability is associated with decreased survival in newly diagnosed IDH-wildtype glioma	9
Red blood cell distribution width to platelet ratio substantiates preoperative survival prediction in patients with newly-diagnosed glioblastoma	9
Predictors of survival and time to progression following operative management of intramedullary spinal cord astrocytomas	9
Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments	9
Adult H3K27M mutated thalamic glioma patients display a better prognosis than unmutated patients	9
Proposed definition of competencies for surgical neuro-oncology training	9
Same-day discharge after brain tumor resection: a prospective pilot study	9
The evolving role of reirradiation in the management of recurrent brain tumors	9
Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastases	9
Identification of magnetic resonance imaging features for the prediction of molecular profiles of newly diagnosed glioblastoma	9
Systemic coagulation is activated in patients with meningioma and glioblastoma	9
Managing cancer and living meaningfully (CALM) in adults with malignant glioma: a proof-of-concept phase IIa trial	9
Revisitation of imaging features of skull base chondrosarcoma in comparison to chordoma	9
Characterization of primary glioma cell lines derived from the patients according to 2016 CNS tumour WHO classification and comparison with their parental tumours	9
A phase I clinical trial of sonodynamic therapy combined with temozolomide in the treatment of recurrent glioblastoma	9
Pre-surgery immune profiles of adult glioma patients	9
Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials	9
Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation	8
Paediatric atypical choroid plexus papilloma: is adjuvant therapy necessary?	8
Postoperative epilepsy and survival in glioma patients: a nationwide population-based cohort study from 2009 to 2018	8
Development of new brain metastases in triple negative breast cancer	8
Long-term follow up of patients with WHO grade 2 oligodendroglioma	8
Combining 18F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study	8
Large language model artificial intelligence: the current state and future of ChatGPT in neuro-oncology publishing	8
Five fraction stereotactic radiotherapy after brain metastasectomy: a single-institution experience and literature review	8
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas	8
Increased proliferation is associated with CNS invasion in meningiomas	8
A consensus definition of supratotal resection for anatomically distinct primary glioblastoma: an AANS/CNS Section on Tumors survey of neurosurgical oncologists	8
Radiation myelopathy following stereotactic body radiation therapy for spine metastases	8
Identification of a high-risk group for brain metastases in non-small cell lung cancer patients	8
Volumetric study reveals the relationship between outcome and early radiographic response during bevacizumab-containing chemoradiotherapy for unresectable glioblastoma	8
Supramaximal versus gross total resection in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4, effect on overall and progression free survival: systematic review and meta-analysis	8
Efficacy of clobazam as add-on therapy in brain tumor-related epilepsy	8
Systematic review of the management of brain metastases from hormone receptor positive breast cancer	8
Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer	8
Coping with glioblastoma: prognostic communication and prognostic understanding among patients with recurrent glioblastoma, caregivers, and oncologists	8
Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR	8
Clinical characteristics and management differences for grade II and III spinal meningiomas	8
Systemic chemotherapy of pediatric recurrent ependymomas: results from the German HIT-REZ studies	8
Aggresomes predict poor outcomes and implicate proteostasis in the pathogenesis of pediatric choroid plexus tumors	8
Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study	8
Endoscopic-assisted surgical approach for butterfly glioma surgery	8
Long non-coding RNA LINC01018 inhibits human glioma cell proliferation and metastasis by directly targeting miRNA-182-5p	8
Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies	8
Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity	8